Superficial x ray therapy Superficial x ray therapy is curative for basal cell and squamous carcinomas of the lids and, with careful fractionation, ectropion, nasolacrimal duct stenosis, and other complications are rarely encountered; the globe is protected by lead 'contact lens' shields placed behind the lids. Conjunctival malignancy (and pterygia) responds well to j-therapy from strontium plaques -made 'double sided' to treat malignancy involving the tarsal as well as bulbar conjunctiva; the 0-rays do not penetrate to the lens in cataractogenic doses. Haemangiomas of the lids and conjunctiva regress with radiotherapy,3 as does the conjunctival Kaposi sarcoma associated with AIDS. 4 Lacrimal gland malignancy may be improved by radiotherapy after surgery, but this does not compensate for radical surgical clearance where this is possible.5
Intraocular uses Low dose radiotherapy may be beneficial in certain benign ocular conditions. Juvenile xanthogranuloma of the iris is extremely radiosensitive,6 and diffuse choroidal haemangiomas also respond well. The dose is delivered by a lenssparing technique developed for retinoblastoma (see below).37
For localised intraocular tumours the now standard use of iodine-125 and ruthenium-106/rhodium-106 ocular plaque brachytherapy has reduced the dose to the operator, and such plaques are replacing the cobalt plaque in both retinoblastoma and melanoma work. The pure ,3-emissions of ruthenium (with their intense dose to the tumour base, causing infarction) may have further advantages in melanoma therapy. The proton beam data on ocular melanomas look impressive8; this too may owe at least some of its effect to damage to tumour vasculature.9 However, the proton work needs to be compared prospectively with conventional plaque therapy. There are good data suggesting that orbital radiotherapy reduces the local relapse rate'" after extrascleral extension of a melanoma.
External beam radiotherapy remains the basis of treatment when focal methods fail to control the spread of retinoblastoma" 12 (Fig 1) . In more advanced disease (where enucleation of an only eye is unacceptable to parents), induction chemotherapy followed by radiotherapy is under intense study with good results.
Other globe malignancies that respond well to radiation are choroidal involvement by leukaemia and metastases from solid cancer. In leukaemic children receiving prophylactic cranial irradiation, the back of the eye receives some radiation and this may explain the lower ocular relapse rate.'3 '4 Choroidal metastases (especially from breast carcinoma) may be associated with cerebral metastases, and thus a computed tomography scan is performed before recommending radiotherapy to the eye alone. Similarly, ocular lymphoma is also associated with an increased incidence of intracerebral disease. 
